HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudio Guarneri Selected Research

Vibratory angioedema

11/2014Amitriptyline and bromazepam in the treatment of vibratory angioedema: which role for neuroinflammation?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudio Guarneri Research Topics

Disease

24Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 11/2007
7Neoplasms (Cancer)
01/2021 - 01/2015
6Infections
08/2022 - 06/2011
6Psoriatic Arthritis
01/2021 - 01/2010
4Melanoma (Melanoma, Malignant)
01/2021 - 08/2012
3Drug-Related Side Effects and Adverse Reactions
01/2021 - 01/2010
3Neuroinflammatory Diseases
11/2014 - 10/2008
3Hypersensitivity (Allergy)
05/2010 - 12/2005
2Latent Tuberculosis
08/2022 - 08/2013
2Urticaria (Hives)
01/2020 - 07/2014
2Chronic Urticaria
01/2020 - 07/2014
2Skin Diseases (Skin Disease)
04/2013 - 03/2009
1Tuberculosis (Tuberculoses)
08/2022
1Virus Diseases (Viral Diseases)
06/2022
1Hepatitis B
06/2022
1Hepatitis
06/2022
1Hepatitis C
06/2022
1Inflammation (Inflammations)
01/2022
1Skin Neoplasms (Skin Cancer)
01/2021
1COVID-19
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Blister (Bulla)
11/2020
1Liver Diseases (Liver Disease)
01/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Familial Mediterranean Fever (Periodic Disease)
11/2019
1Myotonic Dystrophy (Dystrophia Myotonica)
11/2018
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2018
1Visceral Leishmaniasis (Kala Azar)
03/2017
1Leishmaniasis
03/2017
1Drug Eruptions (Drug Eruption)
04/2016
1Lymphoma (Lymphomas)
03/2016
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2016
1Neoplasm Metastasis (Metastasis)
03/2016
1Human Influenza (Influenza)
10/2015
1Diarrhea
10/2015

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
01/2022 - 01/2010
7Adalimumab (Humira)FDA Link
08/2020 - 11/2007
7Etanercept (Enbrel)FDA Link
08/2020 - 11/2007
6Biological ProductsIBA
01/2022 - 11/2007
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2022 - 01/2015
4secukinumabIBA
08/2022 - 01/2018
4Infliximab (Remicade)FDA Link
08/2020 - 11/2007
3Adrenal Cortex Hormones (Corticosteroids)IBA
08/2022 - 07/2014
3Ustekinumab (CNTO 1275)FDA Link
08/2020 - 05/2014
3Histamine Antagonists (Antihistamines)IBA
01/2020 - 07/2014
3AutoantigensIBA
09/2018 - 06/2011
3BenzodiazepinesIBA
11/2014 - 10/2008
2RNA (Ribonucleic Acid)IBA
06/2022 - 01/2020
2SolutionsIBA
01/2022 - 04/2013
2golimumabFDA Link
08/2020 - 03/2017
2AutoantibodiesIBA
09/2018 - 06/2011
2AcitretinFDA Link
09/2016 - 05/2014
2EnzymesIBA
03/2016 - 10/2015
2efalizumab (Raptiva)FDA Link
05/2014 - 11/2007
2Proteins (Proteins, Gene)FDA Link
02/2007 - 12/2005
1InterleukinsIBA
08/2022
1DNA (Deoxyribonucleic Acid)IBA
06/2022
1Transaminases (Aminotransferases)IBA
06/2022
1Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1ixekizumabIBA
01/2022
1avelumabIBA
01/2021
1durvalumabIBA
01/2021
1cemiplimabIBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1tremelimumabIBA
01/2021
1pembrolizumabIBA
01/2021
1B7-H1 AntigenIBA
01/2021
1IpilimumabIBA
01/2021
1NivolumabIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1AntibodiesIBA
01/2021
1ChemokinesIBA
01/2021
1CytokinesIBA
01/2021
1atezolizumabIBA
01/2021
1CollagenIBA
11/2020
1Peptides (Polypeptides)IBA
11/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1Omalizumab (Xolair)FDA Link
01/2020
1Monoclonal AntibodiesIBA
11/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019
1CytosineIBA
11/2018
1Protein Kinases (Protein Kinase)IBA
11/2018
1GuanineIBA
11/2018
1ThymineIBA
11/2018
1amsonic acid (DAS)IBA
09/2018
1Heterogeneous Nuclear Ribonucleoprotein A1IBA
09/2018
1Transcription Factors (Transcription Factor)IBA
07/2018
1Meglumine AntimoniateIBA
07/2017
1Indicators and Reagents (Reagents)IBA
03/2017
1Matrix Metalloproteinases (MMPs)IBA
03/2016
1OsteopontinIBA
03/2016
1Glycoproteins (Glycoprotein)IBA
03/2016

Therapy/Procedure

20Therapeutics
08/2022 - 08/2013
4Biological Therapy
08/2022 - 08/2013
2Chemoprevention
08/2022 - 08/2013
1Phototherapy (Light Therapy)
08/2022
1Aftercare (After-Treatment)
01/2020